563 related articles for article (PubMed ID: 18331250)
21. Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma.
He D; Liu ZP; Honda M; Kaneko S; Chen L
J Mol Cell Biol; 2012 Jun; 4(3):140-52. PubMed ID: 22467683
[TBL] [Abstract][Full Text] [Related]
22. The role of heat shock protein 27 expression in hepatocellular carcinoma in Japan: special reference to the difference between hepatitis B and C.
Harimoto N; Shimada M; Aishima S; Kitagawa D; Itoh S; Tsujita E; Maehara S; Taketomi A; Tanaka S; Shirabe K; Maehara Y
Liver Int; 2004 Aug; 24(4):316-21. PubMed ID: 15287854
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
Murakami Y; Yasuda T; Saigo K; Urashima T; Toyoda H; Okanoue T; Shimotohno K
Oncogene; 2006 Apr; 25(17):2537-45. PubMed ID: 16331254
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion.
Arai I; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Sugita Y; Ota H; Yoshioka S; Nakamura M; Wada H; Damdinsuren B; Kato H; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshita K; Nakamori S; Wakasa K; Sakon M; Monden M
Hepatogastroenterology; 2007; 54(73):167-71. PubMed ID: 17419254
[TBL] [Abstract][Full Text] [Related]
25. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
26. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
Zekry A; Bishop GA; Bowen DG; Gleeson MM; Guney S; Painter DM; McCaughan GW
Liver Transpl; 2002 Mar; 8(3):292-301. PubMed ID: 11910576
[TBL] [Abstract][Full Text] [Related]
27. Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma.
Chang CS; Huang SM; Lin HH; Wu CC; Wang CJ
Hepatogastroenterology; 2007; 54(79):2061-8. PubMed ID: 18251160
[TBL] [Abstract][Full Text] [Related]
28. Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas.
Tornillo L; Carafa V; Richter J; Sauter G; Moch H; Minola E; Gambacorta M; Bianchi L; Vecchione R; Terracciano LM
J Pathol; 2000 Nov; 192(3):307-12. PubMed ID: 11054713
[TBL] [Abstract][Full Text] [Related]
29. The concentration of sFasL, ICE and IL-1beta in the serum and the liver tissue of chronic HCV infected patients.
Lapinski TW
Hepatogastroenterology; 2005; 52(65):1479-83. PubMed ID: 16201101
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
Obika M; Shinji T; Fujioka S; Terada R; Ryuko H; Lwin AA; Shiraha H; Koide N
Intervirology; 2008; 51(1):59-68. PubMed ID: 18349544
[TBL] [Abstract][Full Text] [Related]
31. High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases.
Ohmori S; Shiraki K; Sugimoto K; Sakai T; Fujikawa K; Wagayama H; Takase K; Nakano T
Hum Pathol; 2001 Dec; 32(12):1363-70. PubMed ID: 11774170
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus X protein induced expression of the Nur77 gene.
Lee MO; Kang HJ; Cho H; Shin EC; Park JH; Kim SJ
Biochem Biophys Res Commun; 2001 Nov; 288(5):1162-8. PubMed ID: 11700033
[TBL] [Abstract][Full Text] [Related]
33. The levels of IL-1beta, IL-4 and IL-6 in the serum and the liver tissue of chronic HCV-infected patients.
Lapiński TW
Arch Immunol Ther Exp (Warsz); 2001; 49(4):311-6. PubMed ID: 11726034
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression.
Liu W; Lin YT; Yan XL; Ding YL; Wu YL; Chen WN; Lin X
FASEB J; 2015 Mar; 29(3):1113-23. PubMed ID: 25466893
[TBL] [Abstract][Full Text] [Related]
35. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
Bao ST; Gui SQ; Lin MS
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
[TBL] [Abstract][Full Text] [Related]
36. [Expressions of h-TERT, c-myc, PCNA and cell apoptosis in liver carcinogenesis].
Fu XM; Yang QX; Shao CK; Feng ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):821-3. PubMed ID: 16793609
[TBL] [Abstract][Full Text] [Related]
37. Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Nakopoulou L; Stefanaki K; Vourlakou C; Manolaki N; Gakiopoulou H; Michalopoulos G
Pathol Res Pract; 1999; 195(1):19-24. PubMed ID: 10048090
[TBL] [Abstract][Full Text] [Related]
38. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis.
Custro N; Carroccio A; Ganci A; Scafidi V; Campagna P; Di Prima L; Montalto G
Diabetes Metab; 2001 Sep; 27(4 Pt 1):476-81. PubMed ID: 11547221
[TBL] [Abstract][Full Text] [Related]
39. Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells?
Roskams T; Libbrecht L; Van Damme B; Desmet V
J Pathol; 2000 Jun; 191(2):150-3. PubMed ID: 10861574
[TBL] [Abstract][Full Text] [Related]
40. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
Fukuzawa Y; Takahashi K; Furuta K; Tagaya T; Ishikawa T; Wada K; Omoto Y; Koji T; Kakumu S
J Gastroenterol; 2001 Oct; 36(10):681-8. PubMed ID: 11686478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
